This is what happened when there was a shortage of commercial GLP-1s shortly after they first became available for treating obesity
People with obesity consume more food than is needed to maintain an ideal body weight, despite the discrimination that accompanies being overweight and the wealth of available information that overconsumption is detrimental to health
GLP-1s like Ozempic, Wegovy and Zepbound can range from around $150 to more than $1,000 per month, depending on dosage, formulation and insurance coverage
10.4103/ijem.ijem_423_21 54 ElrakaybiA.LaubnerK.ZhouQ.HugM
Several companies in this guide take pains to test their products, looking at purity and dosage in particular
But for certain groups, it makes a lot of sense